What if we find a defective product?

In this case, please contact us as soon as possible and we will take quick measures to resolve it.

Disposable Powdered or Powder-Free Latex Examination Gloves with CE

Name: Disposable Powdered or Powder-Free Latex Examination Gloves with CE
Brand: Ningbo Nouman Medical Devices Co., Ltd
SKU: 1915015254

Zhejiang, ChinaNingbo Nouman Medical Devices Co., Ltd

US$0.02-0.03

1,000 Pieces

Sample price:US$0.00/piece.Request sample

Product profile

Customization

Available

Material

Latex, Latex

Type

Disposable Medical Supplies

Feature

Eco-Friendly

Customized

Age

Adult

Folded

Transport Package

100 PC Per Box, Non-Sterile

Specification

S, M, L, XL, XXL

Trademark

NOUMAN

Origin

China

Key features

Multiple Size Options: Available in S, M, L, XL, and XXL sizes to fit various needs.

Powdered or Powder-Free: Choose between powdered or powder-free latex examination gloves.

CE Certified: Product meets CE standards for safety and quality assurance.

OEM and ODM Support: Accepts various OEM and ODM orders for custom design needs.

Fast Delivery: Usually takes about 7 working days depending on quantity.

Free Samples Available: Free samples offered for most products, excluding freight costs.

Company profile

Importers and ExportersHigh Repeat Buyers Choice

Ningbo Nouman Medical Devices Co., Ltd

Zhejiang, China

Business Type: Manufacturer/FactoryExport Year: 2015-03-01Nearest Port: Shanghai Port, Ningbo Port, Guangzhou PortAverage Response Time: ≤11.46hTerms of Payment: LC, T/T, PayPal, etc.International Commercial Terms(Incoterms): FOB, EXW, CIF

AI-Powered supplier vetting

SummaryThe supplier is identified as a trading company and limited company, with four employees and product coverage spanning medical devices, respiratory products, catheters, urine bags, wound care, dressings, and other consumer or industrial goods. It reports OEM service for well-known brands and minor customization, but no ODM service and no new products launched in the past year. Export sales account for 90%, with self-operated import and export rights and broad overseas markets. Production information is provided for face masks, including an annual output of 1,000,000,000 pieces, while quality-control testing equipment is stated as zero and several quality procedures are undocumented or unknown. Financial records are indicated for 2021–2023, but no financial results are provided. After-sales and overseas service infrastructure appear limited, with no overseas showroom, agents, branches, or offline trade-show participation.

Supplier typeThe supplier is explicitly classified as a Trading Company and a Limited Company. Its stated scope includes medical-device sales and a manufactured product scope covering respiratory products, hypodermic products, catheters, urine bags, wound care, and dressing sets; however, the employee count is only four.

After-Sales capabilityThe supplier has one-month average lead times in both peak and off-season periods and maintains written procedures and records for assessing service capability. However, it has no overseas showroom, agents, branches, or offline trade-show experience, while complaint-handling and corrective/preventive-action procedures are not documented.

R&D capabilityThe supplier launched no new products during the past year, reports no R&D product-information capability, offers no ODM service, and has no SDK available. These statements indicate limited demonstrated innovation capability, although OEM service for well-known brands is available.

Production capacityThe supplier reports face-mask production of 1,000,000,000 pieces annually, off-season lead time within 15 working days, and six to ten quality-control staff. Nonetheless, quality-control test equipment is stated as zero, and the entity has only four employees overall, creating inconsistency and limiting confidence in the reported production capability.

Customization capabilityThe supplier explicitly provides minor customization and OEM service for popular brands. It does not provide ODM service, so the evidence supports limited customization rather than full product-development customization.